Emyria Limited (ASX:EMD)
Australia · Delayed Price · Currency is AUD 0.0480
0.00 (0.00%)
Sep 9, 2026, 4:10 PM AEST
Emyria Financials Overview
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 4.05 | 4.05 | 1.39 | 2.2 | 1.59 | 1.82 |
Revenue Growth | 76.93% | 190.62% | -36.68% | 38.32% | -12.62% | -7.77% |
Gross Profit Gross Profit Growth | 0.92 | 0.92 | 0.02 | -0.17 | -0.65 | -0.53 |
Operating Income Operating Income Growth | -5.02 | -5.02 | -2.49 | -3.33 | -4.24 | -6.85 |
Net Income Net Income Growth | -6.11 | -6.11 | -3.14 | -11.46 | -5.13 | -7.33 |
Earnings Per Share EPS Growth | -0.01 | -0.01 | -0.01 | -0.03 | -0.02 | -0.03 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 |
|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 |
Clinical Services Other Clinical Services Other Growth | 3.27 | 3.27 | 0.65 |
Clinical Services Mind Body Consulting (Pax Centre) Clinical Services Mind Body Consulting (Pax Centre) Growth | 0.79 | 0.79 | 0.66 |
Corporate Services Corporate Services Growth | - | - | 0.09 |
Total Total Growth | 4.05 | 4.05 | 1.39 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 7.29 | 7.29 | 3.57 | 1.57 | 2.73 | 3.88 |
Total Debt Total Debt Growth | 0.79 | 0.79 | 0.61 | 1.72 | 1.27 | 0.63 |
Net Cash (Debt) Net Cash Growth | 6.5 | 6.5 | 2.96 | -0.15 | 1.46 | 3.25 |
Net Cash Growth | -34.62% | 119.94% | - | - | -54.96% | -41.81% |
Net Cash Per Share Net Cash Per Share Growth | 0.01 | 0.01 | 0.01 | -0.00 | 0.01 | 0.01 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -4.56 | -4.56 | -2.7 | -4.28 | -3.77 | -5.43 |
Capital Expenditures CapEx Growth | -0.37 | -0.37 | -0.01 | -0.16 | -0.02 | -0.05 |
Free Cash Flow Free Cash Flow Growth | -4.92 | -4.92 | -2.72 | -4.44 | -3.79 | -5.48 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 22.68% | 22.68% | 1.76% | -7.61% | -40.66% | -28.82% |
Operating Margin | -123.86% | -123.86% | -178.80% | -151.22% | -266.46% | -375.89% |
Pretax Margin | -150.84% | -150.84% | -225.33% | -520.07% | -322.21% | -402.09% |
Profit Margin | -150.84% | -150.84% | -225.33% | -520.07% | -322.21% | -402.09% |
FCF Margin | -121.48% | -121.48% | -194.91% | -201.75% | -237.89% | -300.74% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 9, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PS Ratio | 9.55 | 7.96 | 12.28 | 7.61 | 24.20 | 28.67 |